Marek's disease virus induces Th-2 activity during cytolytic infection

Viral Immunology

Volumn 21, Issue 2, 2008, Pages 203-213

  Heidari, Mohammad ^a,c   Zhang, Huanmin M ^a   Sharif, Shayan ^b  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6;

BIRD DISEASE; CHICKEN; CONFERENCE PAPER; CONTROL GROUP; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; INOCULATION; MALE; MARDIVIRUS; NONHUMAN; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BIRD DISEASES; CHICKENS; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HERPESVIRUS 2, GALLID; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MALE; MAREK DISEASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; SPLEEN; TH2 CELLS; UP-REGULATION; VIRUS LATENCY;

AVES; GALLUS GALLUS; HERPESVIRIDAE;

EID: 45749115760     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0078     Document Type: Conference Paper

References (54)

1. Calnek BW, Schat KA, Peckham MC, and Fabricant J: Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Dis 1983;27:844-849.
2. Calnek BW: Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 2001;255:25-55.
3. Ross NL: T cell transformation by Marek's disease virus. Trends Microbiol 1999;7:22-29.
4. Calnek BW, Aldinger HK, and Kahn DE: Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis 1970;14:219-233.
5. Witter RL, Nazerian K, and Solmon JJ: Studies on the in vitro replication of turkey herpesvirus. J Natl Cancer Inst 1972;49:1121-1130.
6. Baigent SJ, Petherbridge J, Howes K, Smith LP, Currie RJ, and Nair VK: Absolute quantification of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 2005;123:53-64.
7. Buscaglia C, Calnek BW, and Schat KA: Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J Gen Virol 1988;69:1067-1077.
8. Volpini LM, Calnek BW, Sekellick MJ, and Marcus PI: Stages of Marek's disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression. Vet Microbiol 1995;47:99-109.
9. Davison F, and Kaiser P: Immunity to Marek's disease. In: Marek's Disease: An Evolving Problem. (Davison F, and Nair V, eds.). Institute for Animal Health, Compton Laboratory, UK, 2004, pp. 126-141.
10. Wigley P, and Kaiser P: Avian cytokine in health and disease. Braz J Poult Sci 2002;5:1-14.
11. Mosmann TR, and Sad S: The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol Today 1996;17:138-146.
12. Abbas AK, Murphy KM, and Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
13. Lucey DR, Clerici M, and Shearer GM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;9:532-562.
14. Nakayama H, Kitayama J, Muto T, and Nagawa H: Characterization of intracellular cytokine profile of CD(+) T cells in peripheral blood and tumor-draining lymph nodes of patients with gastrointestinal cancer. Jpn J Clin Oncol 2000;30:301-305.
15. Degen WGJ, van Daal N, Rothwell L, Kaiser P, and Schijns VEJC: Th1/Th2 polarization by viral and helminth infection in birds. Vet Micro 2005;105:163-167.
16. Van der Meide PH, and Schellekens H: Cytokines and the immune response. Biotechnology 1996;8:243-249.
17. Clerici M, and Shearer GM: A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
18. Doncarli A, Stasiuk LM, Fournier C, and Abehsira-Amar O: Conversion to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 1997;27:1451-1458.
19. Filella X, Alcover J, Zarco MA, Beardo P, Molina R, and Ballesta AM: Analysis of T1 and T2 cytokines in patients with prostate cancer. Prostate 2000;44:271-274.
20. Wurster AL, Tanaka T, and Grusby MJ: The biology of Stat4 and Stat6. Oncogene 2000;19:2577-2584.
21. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, and Murphy KM: Development of TH1 CD+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
22. Macatonia SE, Hosken NA, Litton M, et al.: Dendritic cells produce IL-12 and direct the development of TH1 cells from naïve CD4+ T cells. J Immunol 1995;154:5071-5079.
23. Swain SL, Weinberg AD, English M, and Huston G: IL-4 directs the development of Th2-like helper effectors. J Immunol 1990;145:3796-3806.
24. Rincon M, Anguita J, Nakamura T, Fikrig E, and Flavell RA: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD+ T cells. J Exp Med 1997;185:461-469.
25. Rissoan M-C, Grouard G, Briere F, Malefyt RW, and Liu Y-J: Reciprocal control of T helper cell and dendritic cell differentiation. Mol Immunol 1999;39:531-536.
26. Constant SL, and Bottomly K: Induction of Th1 and Th2 CD+ T cell responses: the alternative approaches. Annu Rev Immunol 1997;15:297-322.
27. Kaiser P, Underwood G, and Davison F: Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol 2003;77:762-768.
28. Xing Z, and Schat KA: Expression of cytokine gene in Marek's disease virus-infected chickens and chicken embryo fibroblast culture. Immunology 2000;100:70-76.
29. Xing Z, and Schat KA: Inhibitory effects of nitric oxide and gamma interferon on in vivo and in vitro replication of Marek's disease virus. J Virol 2000;74:3605-3612.
30. Witter RL: Increasing virulence of Marek's disease virus. Avian Dis 1997;41:149-163.
31. Livak KJ, and Schmittgen TD: Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
32. Liu JL, and Kung HJ: Marek's disease herpesvirus transforming protein: a c-Jun analogue with an alternative life style. Virus Genes 2000;21:51-64.
33. Parcells MS, Lin S-F, Dienglewicz RL, et al.: Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 2001;75:5159-5173.
34. Holland MS, and Silva RF: Tissue specific restriction of latent turkey HVT transcription. Acta Virol 1999;43:148-151.
35. Djeraba A, Musset E, Bernardet N, Le Vern Y, and Quere P: Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease. Vet Immunol Immunopath 2002;85:63-75.
36. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, and Murphy WL: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA. 1993;90:9730-9734.
37. Djeraba A, Musset E, van Rooijen N, and Quere P: Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance. Vet Microbiol 2002;86:229-244.
38. Goodbourn S, Didcock L, and Randall RE: Interferons: cell signaling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000;81:2341-2364.
39. Xia C, Liu J, Wu ZG, Lin CY, and Wang M: The interferon-alpha genes from three chicken lines and its effects on H9N2 influenza viruses. Anim Biotechnol 2004;15:77-88.
40. Schwarz H, Harlin O, Ohnemus A, Kaspers B, and Staeheli P: Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res 2004;24:179-184.
41. Okamura H, Nagata K, Komatsu T, et al.: A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 1995;63:3966-3972.
42. Puren AJ, Fantuzzi G, Gu Y, Su MS, and Dinarello CA: Interleukin-18 (IFN-γ inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human mononuclear cells. J Clin Invest 1998;101:711-721.
43. Leung BP, Culshaw S, Gracie JA, et al.: A role for IL-18 in neutrophil activation. J Immunol 2001;167:2879-2886.
44. Abdul-Careem MF, Hunter BD, Parvizi P, Haghighi HR, Thanthrige-Don N, and Sharif S: Cytokine gene expression patterns associated with immunization against Marek's disease in chickens. Vaccine 2007;25:424-432.
45. Abdul-Careem MF, Hunter BD, Sarson AJ, Mayameei A, Zhou H, and Sharif S: Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system. Viral Immunol 2006;19:167-176.
46. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275-283.
47. Antonaci S, and Schiraldi O: Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A review. Immunopharm Immunotox 1998;20:455-472.
48. Becker Y: The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers - a review and hypothesis. Virus Genes 2004;28:5-18.
49. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, and Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
50. Peguet-Navarro J, Moulon C, Caux C, Dalbiez-Gauthier C, Banchereau J, and Schmitt D: Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol 1994;24:884-891.
51. Moore KW, de Waal Malefyt R, Coffman RL, and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
52. de Waal Malefyt R, Yssel H, and De Vries JE: Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-4765.
53. Djeraba A, Musset E, Lowenthal JW, Boyle DB, Chausse A-M, Peloille M, and Quere P: Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus. J Virol 2002;76:1062-1070.
54. Ju DW, Cao X, and Acres B: Intratumoral injection of GMCSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model. Cancer Gene Ther 1997;4:139-149.